Neuralstem, Inc. (CUR):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58466FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Neuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis, Alzheimer’s disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinson’s disease, Huntington’s disease, and cerebral palsy. Neuralstem provides drug treatment for depressive disorder, cognitive complication due to diabetes, post traumatic stress disorder, neurodegeneration, and anti aging. The company develops methods to generate replacement cells from neural stem cells. Neuralstem is headquartered in Germantown, Maryland, the US.

Neuralstem, Inc. Key Recent Developments

Jan 06, 2015: Neuralstem To Present At Biotech Showcase 2015
Nov 12, 2013: Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update
Sep 26, 2013: Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress
Sep 03, 2013: Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
Aug 09, 2013: Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update

This comprehensive SWOT profile of Neuralstem, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neuralstem, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Neuralstem, Inc. – Key Information
Neuralstem, Inc. – Overview
Neuralstem, Inc. – Key Employees
Neuralstem, Inc. – Key Employee Biographies
Neuralstem, Inc. – Key Operational Heads
Neuralstem, Inc. – Major Products and Services
Neuralstem, Inc. – History
Neuralstem, Inc. – Company Statement
Neuralstem, Inc. – Locations And Subsidiaries
Neuralstem, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Neuralstem, Inc. – Business Description
Neuralstem, Inc. – Corporate Strategy
Neuralstem, Inc. – SWOT Analysis
SWOT Analysis – Overview
Neuralstem, Inc. – Strengths
Neuralstem, Inc. – Weaknesses
Neuralstem, Inc. – Opportunities
Neuralstem, Inc. – Threats
Neuralstem, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Neuralstem, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Neuralstem, Inc., Key Information
Neuralstem, Inc., Key Ratios
Neuralstem, Inc., Share Data
Neuralstem, Inc., Major Products and Services
Neuralstem, Inc., History
Neuralstem, Inc., Key Employees
Neuralstem, Inc., Key Employee Biographies
Neuralstem, Inc., Key Operational Heads
Neuralstem, Inc., Other Locations
Neuralstem, Inc., Subsidiaries
Neuralstem, Inc., Key Manufacturing facilities
Neuralstem, Inc., Key Competitors
Neuralstem, Inc., SWOT Analysis
Neuralstem, Inc., Ratios based on current share price
Neuralstem, Inc., Annual Ratios
Neuralstem, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Neuralstem, Inc., Performance Chart
Neuralstem, Inc., Ratio Charts

★海外企業調査レポート[Neuralstem, Inc. (CUR):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amicogen Inc (092040):企業財務及び戦略的SWOT分析
    Summary Amicogen Inc (Amicogen) is a biotechnology company that develops, produces and sells enzyme-based health ingredients. The company offers specialty enzymes, immunological products, new bio-ingredients and nutraceuticals. Its products portfolio includes biocatalyst, chitosanase, lipase PF, nuc …
  • SBE, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SBE, Inc. Mergers and Acquisiti …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務情報
    Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CorVel Corporation (CRVL):企業概要、財務及び戦略的SWOT分析
    Summary CorVel Corporation (CorVel) is a risk management solutions provider. The company specializes in advanced communication and information technology to improve healthcare management for workers’ compensation, group health, auto and liability claims management. It offers service such as patient …
  • MPI Generali Insurans Berhad:企業の戦略・SWOT・財務分析
    SummaryMPI Generali Insurans Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • The PMI Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The PMI Group, Inc. Mergers and …
  • Rex International Holding Ltd (5WH):企業の財務・戦略的SWOT分析
    Summary Rex International Holding Ltd (Rex International), formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, …
  • Kenya Electricity Generating Co Ltd (KGEN)-エネルギー分野:企業M&A・提携分析
    Summary Kenya Electricity Generating Co Ltd (KenGen) is an electricity generation utility. It produces power from hydro, geothermal, thermal, and wind sources. Under power purchase agreements, the company sells power to customers on wholesale basis. Kenya Power and Lighting Company Limited is the au …
  • Mortara Instrument, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mortara Instrument, Inc. Merger …
  • Komatsu Ltd.:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on Komatsu Ltd. providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the core Strengths & We …
  • Dyno Nobel Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dyno Nobel Limited Mergers and …
  • Mevion Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company offers radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving tre …
  • Bolu Cimento Sanayii A.S.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bolu Cimento Sanayii A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Selex ES S.p.A:企業の戦略・SWOT・財務分析
    SummarySelex ES S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Tetra Tech, Inc.:企業の戦略・SWOT・財務分析
    SummaryTetra Tech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Qiagen NV (QIA)-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. Its solutions include sample and assay technologies, bioinformatics and automation systems. Qiagen’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue. The company’s produc …
  • Prometheus Energy Group Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Prometheus Energy Group Inc (Prometheus) is an oil and gas company that supplies liquefied natural gas. The company offers services such as LNG conversion solutions, LNG storage and supply, turnkey fuel solutions, logistics and distribution, and storage, re-gas and field service. It offers t …
  • Windar Photonics AS:企業のM&A・提携動向(発電分野)
    Summary Windar Photonics A/S (Windar Photonics), a subsidiary of Windar Photonics plc is a lighting system developer that provides light detection and ranging systems. The company’s LIDAR system measures both wind speed and direction. It offers products such as 2-beam optimization system, windtimize …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆